Inhibikase Therapeutics Inc (IKT) — Free Cash Flow Generation Index

Latest as of September 2020: 1.00x

Inhibikase Therapeutics Inc (IKT) has a Free Cash Flow Generation Index of 1.00x as of September 2020. Free cash flow of $75.52K represents 1% of operating cash flow ($75.52K). See Inhibikase Therapeutics Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

1.00x

Free Cash Flow / Operating CF

Free Cash Flow

$75.52K

USD

Operating Cash Flow

$75.52K

USD

Capital Expenditures

$0.00

USD

Inhibikase Therapeutics Inc Free Cash Flow Generation Index (2018–2018)

Historical FCF Generation Index trend for Inhibikase Therapeutics Inc across 1 annual periods. Explore Inhibikase Therapeutics Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Inhibikase Therapeutics Inc (2018–2018)

Year-by-year Free Cash Flow Generation Index for Inhibikase Therapeutics Inc. For the full company profile including market capitalisation, see Inhibikase Therapeutics Inc (IKT) market capitalisation.

Year	FCG Index	Free Cash Flow (USD)	Operating CF	Capital Expenditures	YoY Change
2018	1.00x	$714.99K	$714.99K	$0.00	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).